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For centuries, tuberculosis, which is a chronic infection caused by the bacillus Mycobacterium 
tuberculosis has remained a global health problem. The global burden of tuberculosis has 
increased, particularly in the Southern African region, mainly due to HIV, and inadequate health 
systems which has in turn given rise to emergent drug resistant tuberculosis (TB) strains. Bovine 
tuberculosis (BTB) has also emerged as a significant disease with the tendency for inter-species 
spread. The extent of interspecies BTB transmission both in urban and rural communities has not 
been adequately assessed. The phenomenon is of particular importance in rural communities 
where people share habitats with livestock and wildlife (particularly in areas near national parks 
and game reserves). Aerosol and oral intake are the major routes of transmission from diseased 
to healthy individuals, with health care workers often contracting infection nosocomially. 
Although TB control has increasingly been achieved in high-income countries, the disease, like 
other poverty-related infections, has continued to be a disaster in countries with low income 
economies. Transmission of infections occurs not only amongst humans but also between 
animals and humans (and occasionally vice versa) necessitating assessment of the extent of 
transmission at their interface. This review explores tuberculosis as a disease of humans which 
can cross-transmit between humans, livestock and wildlife. The review also addresses issues 
underlying the use of molecular biology, genetic sequencing and bioinformatics as t tools to 
understand the extent of inter-species cross-transmission of TB in a ‘One Health’ context. 
© 2012. The Authors. Licensee: AOSIS OpenJournals. This work is licensed under the Creative Commons Attribution License.
Introduction
Humans and animals have had close interactions as long as we have historical knowledge of 
man. This interaction largely contributes to the evolution and ongoing transmission of shared 
infectious diseases. The need for a systematic global effort to monitor for emerging human is 
important since most major human infectious diseases are thought to have animal origins (Wolfe, 
Dunavan & Diamond 2007), examples being helminths, tuberculosis (TB), brucellosis, foot-and-
mouth disease, leptospirosis, anthrax and Rift Valley fever (RVF). Studies on 1415 pathogenic 
diseases in human and animals (Cleaveland, Laurenson & Taylor 2001) have revealed 61.6% as 
multi-host pathogens, suggesting the need for monitoring these important infectious diseases. 
Available data indicate that more than 80% of human and cattle populations of Africa live in an 
area with partial or no control of bovine TB (Cosivi et al. 1998; WHO/DFID 2006; WHO 2004). 
There is ample evidence that such lack of control and close contact of the two species contributes 
to TB transmission, mostly Mycobacterium bovis from cattle to humans. Perhaps the best-studied 
example and illustration of the effectiveness of control measures was the situation in Western 
Europe (Germany as a good example) prior to the 1950s, where M. bovis infection in cattle was 
common, and M. bovis was present in perhaps 15% of human cases. After strict control measures 
were introduced, M. bovis prevalence dropped effectively to zero in both species, with only the 
occasional reactivation case seen in the elderly, or in new immigrants coming from areas where 
M. bovis is not controlled. The extent of M. bovis infection and disease is not properly known in 
almost every environment. Many tests, for example, tuberculin skin test (TST) and assays based on 
gamma interferon response may indicate exposure, but neither indicates disease nor an indication 
of whether infection is from Mycobacterium tuberculosis, M. bovis, or possibly other mycobacteria, 
particularly those of the M. tuberculosis complex. The usual assumption is that if the test is done 
in a bovid, then the presence of or exposure to M. bovis is indicated, whereas if done in humans, 
then M. tuberculosis is indicated. However, this may not be true, since cross–reactivity does occur. 
At this stage, the gold standard for identification remains microbiological, whether culture or 
done by molecular techniques. Tuberculosis can present in many ways, and in humans, a frequent 
manifestation of bovine TB is extra-pulmonary tuberculosis (EPTB). Unfortunately, M. tuberculosis 
can also present in extra-pulmonary form, although less frequently. Extra-pulmonary tuberculosis 
driven by M. tuberculosis can also occur more frequently in children and individuals who are 
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immunocompromised, for example, HIV positive (Connolly 
et al. 2004; Heymann 2011). Therefore, although EPTB can 
be used as an indicator (or rather, index of suspicion) of 
M. bovis infection in humans, this should only be considered 
seriously in areas or individuals where exposure to bovine 
TB is likely or suspected. Nevertheless, EPTB prevalence can 
be used as an indicator of M. bovis in humans. The control of 
this disease clearly requires significant efforts on the part of 
both veterinary and human health care practitioners and this 
article will address this cross-species issue in particular.
Transmission at the human-
livestock-wildlife interface
Transmission of bovine tuberculosis from animals to humans 
can occur most likely via aerosol exposure or through 
consumption of un-pasteurised milk and other affected 
animal products. Reports from Tanzania covering the period 
from 2008 to 2009 suggest that EPTB accounted for over 20% 
of the cases of TB and showed a marginal annual increment 
(National TB Control Program Report 2011, in preparation). 
This high level prevalence of EPTB plus other data (Cook 
et al. 1996) suggests the presence of mycobacteria other than 
M. tuberculosis occur extensively in the Tanzanian population. 
We note that more extra-pulmonary cases are contributed 
by M. tuberculosis than M. bovis by total case load; however, 
such a high prevalence rate is unlikely to be due entirely to 
M. tuberculosis. A study by Cook et al. (1996) in Monze District 
of Zambia, reported for cattle in larger herds, in households 
with previously report of human tuberculosis cases (preceding 
12 months) to be more likely tuberculin test positive (six 
times) than those without previous reported human TB case. 
This could reflect TB cross-transmission between species. In 
the same year, a variety of different mycobacteria, including 
M. tuberculosis, were isolated from dairy cattle and milk in 
Tanzania (Kazwala et al. 1998). Studies in the Netherlands 
(Majoor et al. 2011) indicate mainly (58.9%) extra-pulmonary 
M. bovis infection in humans. Although individuals may 
develop the pulmonary form of M. bovis disease, person-
to-person transmission is said to be unlikely, based on data 
from genotype analysis (Majoor et al. 2011). There are reports 
on elephant-to-human transmission of tuberculosis due to 
indirect exposure to aerosolised M. tuberculosis (Murphree 
et al. 2011). The infection has been exacerbated by delayed 
or inadequate disease control practices. Other reports have 
indicated M. tuberculosis as an emerging disease in Asian 
elephants in zoological collections (Mikota et al. 2001). 
Finally, there are unpublished reports that M. tuberculosis has 
been detected in a number of Ethiopian cattle, transferred 
from the human owners directly to the animals (Paul van 
Helden from D Young pers. comm., n.d.). 
The implication, impact and challenges underlying zoonotic 
tuberculosis to both humans and animals has been repeatedly 
emphasised (Cataldi & Romano 2007; Cleaveland et al. 2005; 
Kazwala et al. 1998, 2001a; Michel 2002b; Michel et al. 2006; 
Michel, Müller & Van Helden 2010; Woodroffe et al. 2009). Yet 
diagnosis by acid fast smear is still widely used and often the 
only non-clinical diagnostic since it is affordable. But this test, 
despite being the keystone of tuberculosis diagnosis in Africa, 
does not permit differentiation between M. tuberculosis 
and M. bovis, or any other mycobacterial species. Thus, it is 
essential that better diagnostics are applied in order that we 
may know the extent and nature of the problem at hand. In 
addition, the conventional means of control are difficulty to 
apply once the infection enters into wildlife species which 
are common maintenance hosts in most cases (Michel 2002a; 
Palmer 2007). Animals are regarded to be the main source 
of zoonotic tuberculosis infection in humans. However, as 
outlined above, reports also indicate that humans are not 
the only victims from cross-species infection by tuberculosis, 
but are also potential sources of infection, even to free-living 
wildlife at their interface (Alexander et al. 2002). This creates 
room for researchers to look at the disease from both sides 
of the coin. Aerosol and oral transmission are the major 
routes of transmission in patients, with health care workers 
contracting infection nosocomially. In wildlife, similar 
routes are proposed with carnivores and omnivores said 
to contract infections via scavenging of bovine tuberculosis 
infected carcasses and killing and consumption of infected 
prey such as antelope or wild bovids (Michel et al. 2006). 
This is evident from proven bovine tuberculosis in predators 
(Keet et al. 2001). 
Intensification of animal-human contact enhances the 
likelihood of cross-over and an increased risk of transmission 
for both M. tuberculosis as well as M. bovis at the interface. 
Cross-transmission in infectious disease is not a newly 
emerging view but linked to the co-evolution of humans, 
the animals with which they co-exist and evolve and the 
microorganisms in their environment (Diamond 2002; Wirth 
et al. 2008). Once a pathogen has crossed over into a new 
species of host, for example from animal to human, it may 
transform into a specialised pathogen of humans Wolfe 
et al. (2007).
A number of studies have been done reflecting the impact 
bovine tuberculosis may pose to wildlife (Alexander 
et al. 2002; Cleaveland et al. 2005; De Garine-Wichatitsky 
et al. 2010; Michel et al. 2006, 2007). Others have focused on 
livestock alone (Aranaz et al. 2003; Cousins 2001; Durnez 
et al. 2009, 2011; Shirima, Kazwala & Kambarage 2003; 
Kazwala et al., 2001b) and others in humans alone (Kazwala 
et al. 1998; Mfinanga et al. 2004; Ngowi et al. 2008), mostly 
using conventional diagnostic and evaluation means of the 
disease. A review published recently (Michel et al. 2010) 
pinpointed bovine tuberculosis in particular, to be a disease 
of low-income countries with a multifaceted impact affecting 
the health of livestock, humans and the ecosystems. In the 
same review, it is also speculated that the disease is likely to 
increase in situations where HIV and AIDS occurs. 
Recent work has characterised M. bovis isolates and reported 
that regional clonal complexes predominating in specific 
areas occur, for example Af1 M. bovis complex in west-
central Africa (Muller et al. 2009), Af2 prevalent in East Africa 
(Berg et al. 2011) as well as European 1 with European origin 
(Smith et al. 2011). Thus we do not yet know for certain whether 
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M. bovis is an endemic or alien disease to Africa, or whether 
it is endemic to some areas (e.g. some parts of West and East 
Africa) but alien to others. Certainly, there is no evidence to 
suggest that any form of M. bovis is endemic or indigenous to 
South Africa. Better unpacking of this information is needed, 
since it may impact on how we view this disease and respond 
to it. We do not know the relative frequency of the African 
and European type M. bovis in any area and it may be that the 
European variety dominates as an alien invasive organism. It 
may be that indigenous African cattle and wildlife in some 
areas are relatively resistant to bovine TB, which we may 
take advantage of in our responses to the disease. 
Several studies and reviews surveying the zoonotic TB status 
in animals and humans have been published (Cataldi & 
Romano 2007). Different study designs, methods of analysis 
and various study-dependent objectives largely influence the 
outcome and interpretation of these studies. Differences in 
outcomes amongst these different studies nevertheless reflect 
the diversity of disease dynamics in different communities 
and methodological shortcomings have been revealed 
(Heldal et al. 2003; Murray & Alland 2002). 
A new concern is that cross-species transmission may 
play a role in emergent drug resistant tuberculosis. 
Mycobacterium bovis is inherently resistant to pyrazinamide, 
one of the four first line antibiotics, and thus inadequate and/
or inappropriate treatment of apparent M. tuberculosis in a 
human can easily result in acquisition of further resistance in 
M. bovis. Drug-resistant M. bovis in human disease has already 
been reported in a number of countries (Blazquez et al. 1997; 
Hughes et al. 2003; Sechi et al. 2001). This is essentially risky 
for African populations due to a close association of TB with 
HIV and often poor patient adherence and problems with 
implementing a good DOTS programme as advocated by 
Word Health Organisation (WHO). Likewise, transmission 
of drug resistant M. tuberculosis to animals and back to 
humans is not impossible, although likely to be very rare. In 
rural communities, milk pasteurisation is not common and 
M. bovis survival in cow’s milk is effective. Therefore, despite 
reports that humans are less susceptible to bovine TB than 
M. tuberculosis (De la Rua-Domenech 2006) we cannot ignore 
these known problems and complications. 
Possible contributing factors to 
increased transmission at the 
interface
The main problem with identifying or quantifying the 
transmission of zoonotic tuberculosis at the human-animal 
interface is the failure to adopt appropriate diagnostic tools 
that can discriminate between M. bovis and M. tuberculosis, 
or other species of mycobacteria at routine diagnostic 
settings, particularly in low-income countries. This is not 
surprising, given the huge burden of disease, particularly of 
M. tuberculosis and the low per capita income of those 
countries. A further reason for this problem is that many 
clinicians show no interest in differentiating the causative 
agent, since initial treatment is the same. As a result the 
contribution of mycobacteria such as M. bovis to the global 
human TB burden is almost certainly underestimated. Despite 
these problem and long before such discriminatory tests 
became available, the test-and-slaughter scheme has proven 
to be an efficient control method for bovine tuberculosis in 
developed countries, although it is considered expensive 
(Michel et al. 2010) and is not yet accepted by all farmers 
(Bennett 2009; Torgerson & Torgerson 2009). Consequently, 
the joint impact of these important pathogens to national and 
global economies is still unknown. 
Different and inflexible policies guiding the practice of 
veterinary and medical practitioners are also potential 
barriers to what may be an immediate positive impact on 
zoonotic TB control strategies in most developing countries. 
The prevalence of human TB and livestock TB has been 
reported to correlate (Cosivi et al. 1998) despite contradicting 
reports on animal-human active transmission of zoonotic TB 
(Cousins, Williams & Dawson 1999; Dankner & Davis 2000; 
Dankner et al. 1993; Jalava et al. 2007; Romano et al. 1995, 1996; 
Zumarraga et al. 1999). The absence of genetic relatedness 
amongst M. bovis isolates leading to these controversies is in 
all likelihood simply a matter of incomplete sampling and 
reactivation disease (Mignard, Pichat & Carret 2006). This 
is supported by a report from Baker et al. (2006) who found 
many genotypes in human TB identical to patterns from 
farmed and wild animals. With the current advancement 
in molecular techniques for evaluation of infectious 
agents, exploiting these skills and using them for both 
epidemiological and evolutionary analysis of mycobacterial 
populations infecting humans and animals (Baker et al. 2004) 
and assessment of their cross-transmission amongst these 
species is possible and important.
Pathogen flow and disease dynamics of M. bovis has been 
broadly reported in South Africa’s wildlife and livestock 
(Michel 2002b; Michel et al. 2006, 2010) showing that the 
African buffalo is the major reservoir of infection in wildlife 
in that ecosystem. Thus, although originally a naïve host and 
infected by cross-over from cattle initially, the buffalo have 
become a source of infection for many other species, through 
dissemination of bacilli in the environment or predation 
(Keet et al. 1996; Michel 2002a, 2002b; Michel et al. 2004, 2006, 
2007, 2010). Although fairly the extensive studies have been 
done in the South African National Parks, little has been done 
in the large National Parks of Tanzania, such as Serengeti, 
Ruaha and Mikumi, where a large number of buffaloes are 
found. Unlike the South African parks, where there is little 
or no contact with domestic stock, in Tanzania infected 
buffalo could be reservoirs of bovine TB contributing to the 
increasing prevalence of tuberculosis in both humans and 
livestock, through mechanisms described below. 
Some legal and controlled hunting is allowed in open areas, 
Game Controlled Areas (GCAs) and game reserves for game-
meat in Tanzania but there is no established meat inspection 
to monitor TB or other infections in these game products. In 
addition, people around game reserves and national parks 
practice illegal or bush meat hunting and hidden sale of 
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game meat in villages and therefore difficult to control or 
conduct meat inspection. The situation is worsened during 
extensive droughts when food becomes scarce, resulting 
in increased poaching activities. In such circumstances, the 
contact between species at their interface and probability of 
infected meat entering the human food chain may increase 
with consequent spillover and cross-transmission of infection 
amongst populations (Osofsky et al. 2005). In addition, the 
life expectancy of livestock held by small scale farmers is 
generally higher than in commercial livestock keeping and 
bovine tuberculosis as a chronic and progressive disease 
manifests itself more often in older animals, under nutritional 
or productive stress (Michel et al. 2006). This socio-cultural 
behaviour when combined with close proximity with wildlife 
is detrimental to either ecosystem in terms of tuberculosis 
cross-transmission.
Molecular epidemiological 
– diagnostic tools and their 
application in developing countries
The development of molecular tools for identification of 
M. bovis, the known zoonotic TB causing mycobacterium, 
and differentiation from other members of the M. tuberculosis 
complex have allowed the discovery of more cases in 
retrospective studies and have suggested new forms of 
transmission (Cataldi & Romano 2007). In addition, the 
usefulness of molecular tools in normal practices of 
prevention and control of tuberculosis has been addressed 
(McNabb, Braden & Navin 2002). Genotyping of mycobacterial 
isolates in the mycobacterium tuberculosis complex has 
the ability to distinguish amongst clonal populations and 
provide key information on disease dynamics. However, 
this approach has been insufficiently applied in developing 
countries due to lack of facilities, resources and scarce skilled 
personnel. Molecular techniques such as PCR are powerful 
tools to identify mycobacteria and can potentially be used 
on cultured and original biological samples. Application of 
more than one molecular technique can complement each 
other in differentiating various strains or isolates and shed 
light on the phylogenetics and ultimately the transmission 
chains, thereby allowing for improved control or policy 
development (Michel et al. 2010).
Such actions require specific and dedicated support and 
government commitment for wide use and sustainability. 
Very few molecular epidemiological studies on tuberculosis 
have been done in Tanzania and even those few have been 
made possible mainly through collaborations. These studies 
have focused on the epidemiology of the disease in livestock 
or in wildlife, or have dealt with the disease in humans. As 
yet, tracking transmission across species using molecular 
tools such as RFLP (Michel 2002b) in Tanzania has been 
limited or almost non-existent. 
One Health as a Disease control 
strategy
Management of diseases in wildlife is complex because 
the current wildlife policy in Tanzania does not generally 
advocate treatment or vaccination to control infection and 
disease. Treatment or vaccination is only allowed if a disease 
outbreak occurs in endangered wildlife species or the 
outbreak poses a threat to the species population. Of course 
it must also be acknowledged that vaccination is not effective 
in all diseases, TB being one such example. Moreover, the 
logistics and funding required for treatment or vaccination 
in wildlife also make it largely impractical because it is 
almost impossible to get all animals, except perhaps very 
rare species (Osofsky et al. 2005). In most of Africa, small 
scale farmer’s livestock and their products are largely 
excluded from veterinary and veterinary public health 
control measures (Michel et al. 2004). Therefore, a change in 
policy and the political will that is necessary to support such 
recommendations will be necessary to reduce infection and 
disease. We need a two-pronged approach to address both 
technical and political issues to formulate a way forward. A 
policy that is focused on control of zoonotic TB and which 
addresses the need for a ‘One Health’ approach, through 
which veterinary and medical professions as well as social 
scientists and ecologists can work together to limit disease 
would be a new venture with a chance of success. 
Conclusions
Due to differences in national policies which guide different 
sectors of the Tanzanian economy (health, livestock and 
wildlife), the immediate suggested approach would be 
to prevent contact between wildlife and livestock and to 
control the disease (TB) in livestock through introduction 
of a compulsory test and slaughter practice, a proven recipe 
in other countries. This will reduce the transmission of 
disease not only between livestock and humans, but also 
limit transmission of infection from wildlife and vice versa. 
The implementation should include a policy that strictly 
prohibits livestock introgression to national parks and game 
reserves by implementing a boundary, beyond which animal 
keeping is unlawful. This however, has a problem in that 
even if livestock are kept out of this zone, wildlife will not 
understand that zone and will move into it, such that the 
‘zone’ will then move outwards to contact livestock again 
posing a big challenge on the strategy. The other remaining 
challenge is to convince policy makers and creating 
awareness in livestock keepers concerning the magnitude of 
the problem its consequences and the importance of disease 
control even impacts across international borders. The 
Serengeti National Park, for example, spans two countries 
and animal movement to the other side of the park into the 
Kenyan Maasai Mara might be contributing to an increased 
transmission risk not only to the wildlife in that country but 
also the livestock and humans in the neighbouring country. 
This is also applicable from Kenya to Tanzania, of course, as 
it would be for any transfrontier park. 
Although some work has been done we still do not have any 
accurate estimate of the extent of human-animal cross-species 
transmission in Tanzania, possibly elsewhere, with regard 
to TB. Much of this is because of the technical complexity 
and cost of cultures and speciation. In addition, additional 
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problems include bias in previous studies owing to sampling 
from urban areas and pulmonary samples as well as challenge 
of detecting infection rather than disease and attributing 
it to transmission, together with the assumption that it is a 
particular species of mycobacterium. Studies are currently 
underway in and around the Serengeti National Park under 
the umbrella of the Southern Centre for Infectious Disease 
Surveillance (SACIDS), to try to establish the clear trans-
boundary interaction between human-livestock-wildlife 
and TB transmission. Once one has a clear understanding of 
these factors, it may be possible to suggest an appropriate 
‘One Health’ approach to arrest pathogen flow and interrupt 
prevailing disease dynamics across species. In our opinion, 
research aiming to identify and characterise pathogens (not 
only mycobacterial species) of animals with potential to be 
infective to humans (Wolfe et al. 2007) should be prioritised 
in order to enable us know the potential source of diseases to 
become proactive and hopefully prevent or limit outbreaks. 
To successfully implement this strategy, a sustainable 
and efficient collaborative approach involving multiple 
stakeholders from various sectors and working groups 
is needed. 
Acknowledgement
The SACIDS is acknowledged for providing a Postdoctoral 
Research Fellowship to EM. Financial support was received 
from the Wellcome Trust. Prof. Mark Rweyemamu, 
The Executive Director of SACIDS is acknowledged for 
stimulating the idea and advice. The London International 
Development Centre in the UK and staff are acknowledged 
for collaboration. Prof. Jeff Waage is particularly 
acknowledged for his dedicated efforts to provide 
complementary material support and encouragement 
during preparation of this manuscript. Sian Brown and Sue 
van Rensburg are acknowledged for the illustrative pictures 
used in this manuscript. Muhimbili University of Health and 
Allied Science, particularly, the School of Medicine and The 
Department of Biochemistry are acknowledged for providing 
time for preparation of this work. 
Competing interests 
The authors declare that they have no financial or personal 
relationship(s) which may have inappropriately influenced 
them in writing this paper.
Authors’ contributions 
E.V.M. (Muhimbili University of Health and Allied Sciences)
participated in reviewing the literature, conceptualising, 
drafting and writing the manuscript. B.Z.K. (Muhimbili 
University of Health and Allied Sciences) participated in 
initial drafting of the manuscript and critical manuscript 
review. S.K. (The Royal Veterinary College) participated 
in critical manuscript review. L.G. (The Royal Veterinary 
College) assisted in critical manuscript review and focusing 
of the manuscript. G.S.K. (Tumaini University) critically 
reviewed the manuscript. J.D.K. (Tanzania Wildlife Research 
Institute) conceived the idea, assisted in drafting and critical 
review of the manuscript. P.v.H. (University of Stellenbosch) 
assisted in critical review of the manuscript. P.G.F. (London 
School of Hygiene and Tropical Medicine) assisted in drafting 
the manuscript and critically reviewed the manuscript. 
M.I.M. (Muhimbili University of Health and Allied Sciences) 
directed the whole process of drafting and critical review of 
manuscript.
References
Alexander, K.A., Pleydell, E., Williams, M.C., Lane, E.P., Nyange, J.F. & Michel, A.L., 
2002, ‘Mycobacterium tuberculosis: An emerging disease of free-ranging 
wildlife’, Emerging Infectious Diseases 8, 598–601. http://dx.doi.org/10.3201/
eid0806.010358, PMid:12023916
Aranaz, A., Cousins, D., Mateos, A. & Domı´Nguez, L., 2003, ‘Elevation of 
Mycobacterium tuberculosis subsp. caprae Aranaz et al. 1999 to species rank as 
Mycobacterium caprae comb. nov., sp. nov.’, International Journal of Systematic 
and Evolutionary Microbiology 53, 1785–1789.
Baker, L., Brown, T., Maiden, M.C. & Drobniewski, F., 2004, ‘Silent nucleotide 
polymorphisms and a phylogeny for Mycobacterium tuberculosis’, Emerging 
Infectious Diseases 10, 1568–1577. http://dx.doi.org/10.3201/eid1009.040046, 
PMid:15498158
Baker, M.G., Lopez, L.D., Cannon, M.C., De Lisle, G.W. & Collins, D.M., 2006, 
‘Continuing Mycobacterium bovis transmission from animals to humans in New 
Zealand’, Epidemiology and Infection 134, 1068–1073. http://dx.doi.org/10.1017/
S0950268806005930, PMid:16569268
Bennett, R.M., 2009, ‘Farm costs associated with premovement testing for bovine 
tuberculosis’, Veterinary Record 164, 77–79. http://dx.doi.org/10.1136/
vr.164.3.77, PMid:19151404
Berg, S., Garcia-Pelayo, M.C., Muller, B., Hailu, E., Asiimwe, B., Kremer, K. et al., 2011, 
‘African 2, a clonal complex of Mycobacterium bovis Epidemiologically Important 
in East Africa’, Journal of Bacteriology 193, 670–678. http://dx.doi.org/10.1128/
JB.00750-10, PMid:21097608
Blazquez, J., De Los, E., Monteros, L.E., Samper, S., Martin, C., Guerrero, A. et al., 1997, 
‘Genetic characterization of multidrug-resistant Mycobacterium bovis strains from 
a hospital outbreak involving human immunodeficiency virus- positive patients’, 
Journal of Clinical Microbiology 35, 1390–1393. PMid:9163450  
Brosch, R., Gordon, S.V., Marmiesse, M., Brodin, P., Buchrieser, C., Eiglmeier, K. et al., 
2002, ‘A new evolutionary scenario for the Mycobacterium tuberculosis complex’, 
Proceedings of the National Academy of Sciences of the United States of America 
99, 3684–3689. http://dx.doi.org/10.1073/pnas.052548299, PMid:11891304
Cataldi, A. & Romano, M.I., 2007, ‘Tuberculosis caused by other members of the 
Mycobacterium tuberculosis complex’, in Tuberculosis: From basic science to 
patient care, viewed n.d., from http://www.tuberculosis.textbook.com
Cleaveland, S., Laurenson, M.K. & Taylor, L.H., 2001, ‘Diseases of humans and 
their domestic mammals: Pathogen characteristics, host range and the risk of 
emergence’, Philosophical Transactions of the Royal Society of London. Series 
B: Biological Sciences 356, 991–999. http://dx.doi.org/10.1098/rstb.2001.0889, 
PMid:11516377
Cleaveland, S., Mlengeya, T., Kazwala, R.R., Michel, A., Kaare, M.T., Jones, S.L. et al., 
2005, ‘Tuberculosis in Tanzanian wildlife’, Journal of Wildlife Diseases 41, 446–
453. PMid:16107683
Cook, A.J.C., Tuchili, L.M., Buve, A., Foster, S.D., Godfrey-Faussett, P., Pandey, G.S. 
et al., 1996, ‘Human and bovine tuberculosis in the Monze District of Zambia: 
A cross-sectional study’, British Veterinary Journal 152, 37–46. http://dx.doi.
org/10.1016/S0007-1935(96)80084-4
Connolly, M.A., Gayer, M., Ryan, M.J., Salama, P., Spiegel, P. & Heymann, D.L., 2004, 
‘Communicable diseases in complex emergencies: Impact and challenges’, The 
Lancet 364, 1974–1983. http://dx.doi.org/10.1016/S0140-6736(04)17481-3
Cosivi, O., Grange, J.M., Daborn, C.J., Raviglione, M.C., Fujikura, T., Cousins, D. et 
al., 1998, ‘Zoonotic tuberculosis due to Mycobacterium bovis in developing 
countries’, Emerging Infectious Diseases 4, 59–70. http://dx.doi.org/10.3201/
eid0401.980108, PMid:9452399
Cousins, D.V., 2001, ‘Mycobacterium bovis infection and control in domestic livestock’, 
Scientific and Technical Review of the International Office of Epizootics 20, 71–85.
Cousins, D.V., Williams, S.N. & Dawson, D.J., 1999, ‘Tuberculosis due to 
Mycobacterium bovis in the Australian population: DNA typing of isolates, 
1970–1994’, International Journal of Tuberculosis and Lung Disease 3, 722–731. 
PMid:10460106
Dankner, W.M. & Davis, C.E., 2000, ‘Mycobacterium bovis as a significant cause of 
tuberculosis in children residing along the United States-Mexico Border in 
the Baja California Region’, Pediatrics 105, e79. http://dx.doi.org/10.1542/
peds.105.6.e79, PMid:10835092
Dankner, W.M., Waecker, N.J., Essey, M.A., Moser, K., Thompson, M. & Davis, C.H., 
1993, ‘Mycobacterium bovis infections in San Diego: A clinico-epidemiologic 
study of 73 patients and a historical review of a forgotten pathogen’, Medicine 
(Baltimore) 72, 11–37.
De Garine-Wichatitsky, M., Caron, A., Gomo, C., Foggin, C., Dutlow, K., Pfukenyi, D. et 
al., 2010, ‘Bovine tuberculosis in buffaloes, Southern Africa’, Emerging Infectious 
Diseases 16, 884–885. PMid:20409396
Proceeding
doi:10.4102/ojvr.v79i2.501http://www.ojvr.org
Page 6 of 6
De La Rua-Domenech, R., 2006, ‘Human Mycobacterium bovis infection in the United 
Kingdom: Incidence, risks, control measures and review of the zoonotic aspects 
of bovine tuberculosis’, Tuberculosis 86, 77–109. http://dx.doi.org/10.1016/j.
tube.2005.05.002, PMid:16257579
Diamond, J., 2002, ‘Evolution, consequences and future of plant and animal 
domestication’, Nature 418, 700–707. http://dx.doi.org/10.1038/nature01019, 
PMid:12167878
Durnez, L., Katakweba, A., Sadiki, H., Katholi, C.R., Kazwala, R.R., Machang’u, 
R.R. et al., 2011, ‘Mycobacteria in terrestrial small mammals on cattle farms 
in Tanzania’, Veterinary Medicine International 2011, 1–12. http://dx.doi.
org/10.4061/2011/495074, PMid:21785686
Durnez, L., Sadiki, H., Katakweba, A., Machang’u, R., Kazwala, R., Leirs, H. et al., 2009, 
‘The prevalence of Mycobacterium bovis-infection and atypical mycobacterioses 
in cattle in and around Morogoro, Tanzania’, Tropical Animal Health and Production 
41, 1653–1659. http://dx.doi.org/10.1007/s11250-009-9361-4, PMid:19437127
García-Pachón, E. & Rodríguez, J.C., 2005, ‘Molecular rpidemiology of tuberculosis: 
Main findings and their application in Spain’, Archives of Bronconeumology 41, 
618–624. http://dx.doi.org/10.1016/S1579-2129(06)60296-6
Heymann, D.L., 2011, ‘Control of Communicable Diseases Manual 18th edition: 
Tuberculosis’, ICD-9 010-018; ICD-10 A15-A19, viewed n.d., from http://myph.
org/html/CCDM_Tuberculosis.html
Heldal, E., Dahle, U.R., Sandven, P., Caugant, D.A., Brattaas, N., Waaler, H.T. et al., 
2003, ‘Risk factors for recent transmission of Mycobacterium tuberculosis’, 
European Respiratory Journal 22, 637–642. http://dx.doi.org/10.1183/09031936.
03.00019103, PMid:14582917
Hughes, V.M., Skuce, R., Doig, C., Stevenson, K., Sharp, J.M. & Watt, B., 2003, 
‘Analysis of multidrug-resistant M. bovis from three clinical samples from 
Scotland’, International Journal of Tuberculosis and Lung Diseases 7, 1191–1198. 
PMid:14677895
Jalava, K., Jones, J.A., Goodchild, T., Clifton-Hadley, R., Mitchell, A., Story, A. et al., 
2007, ‘No increase in human cases of M. bovis disease despite resurgence of 
infections in cattle in the United Kingdom’, Epidemiology and Infection 135, 40–
45. http://dx.doi.org/10.1017/S0950268806006509, PMid:16740186
Kazwala, R.R., Daborn, C.J., Kusiluka, L.J., Jiwa, S.F., Sharp, J.M. & Kambarage, D.M., 
1998, ‘Isolation of Mycobacterium species from raw milk of pastoral cattle of the 
southern highlands of Tanzania’, Tropical Animal Health and Production 30, 233–
239. http://dx.doi.org/10.1023/A:1005075112393, PMid:9760715
Kazwala, R.R., Daborn, C.J., Sharp, J.M., Kambarage, D.M., Jiwa, S.F.H. & Mbembati, 
N.A., 2001a, ‘Isolation of Mycobacterium bovis from human cases of cervical 
adenitis in Tanzania: a cause for concern?’, International Journal of Tuberculosis 
and Lung Diseases 5, 87–91. PMid:11263522
Kazwala, R.R., Kambarage, D.M., Daborn, C.J., Nyange, J., Jiwa, S.F.H. & Sharp, J.M., 
2001b, ‘Risk factors associated with the occurrence of bovine tuberculosis in cattle 
in the southern highlands of Tanzania’, Veterinary Research Communications 25, 
609–614. http://dx.doi.org/10.1023/A:1012757011524, PMid:11767006
Keet, D.F., Kriek, N.P.J., Bengis, R.G. & Michel, A.L., 2001, ‘Tuberculosis in kudus 
(Tragelaphus strepsiceros) in the Kruger National Park’, Onderstepoort Journal of 
Veterinary Research 68, 225–230. PMid:11769355
Keet, D.F., Kriek, N.P.J., Penrith, M-L., Michel, A. & Huchzermeyer, H., 1996, 
‘Tuberculosis in buffaloes (Syncerus caffer) in the Kruger National Park: Spread 
of the disease to other species’, Onderstepoort Journal of Veterinary Research 63, 
239–244. PMid:8917861
Majoor, C.J., Magis-Escurra, C., Van Ingen, J., Boeree, M.J. & Van Soolingen, D., 2011, 
‘Epidemiology of Mycobacterium bovis disease in humans, The Netherlands, 
1993–2007’, Emerging Infectious Diseases 17, 457–463. PMid:21392437
Mazet, J.A.K., Clifford, D.L., Coppolillo, P., Deolalikar, A.B., Erickson, J.D. & Kazwala, 
R.R., 2009, ‘A “One Health” approach to address emerging zoonoses: The HALI 
project in Tanzania’, PLoS Medicine 6, e1000190. http://dx.doi.org/10.1371/
journal.pmed.1000190, PMid:20016689
McNabb, S.J., Braden, C.R. & Navin, T.R., 2002, ‘DNA fingerprinting of Mycobacterium 
tuberculosis: Lessons learned and implications in the future’, Emerging 
Infectious Diseases 8, 1314–1319. http://dx.doi.org/10.3201/eid0811.020402, 
PMid:12453363
Mfinanga, S.G., Morkve, O., Kazwala, R.R., Cleaveland, S., Sharp, M.J., Kunda, J. et 
al., 2004, ‘Mycobacterial adenitis: Role of Mycobacterium bovis, non-tuberculous 
mycobacteria, HIV infection, and risk factors in Arusha, Tanzania’, East African 
Medical Journal 81, 171–178. PMid:15884281
Michel, A., De Klerk, L-M., Van Pittius, N., Warren, R. & Van Helden, P., 2007, ‘Bovine 
tuberculosis in African buffaloes: Observations regarding M. bovis shedding into 
water and exposure to environmental mycobacteria’, BMC Veterinary Research 3, 
23. http://dx.doi.org/10.1186/1746-6148-3-23, PMid:17900356
Michel, A.L., 2002a, ‘The epidemiology of M. bovis infection in South African wildlife’, 
in Abstracts of the Veterinary European Network on Mycobacterium (VENOM) 
Symposium: DNA Fingerprinting of Bovine TB strains, October 24–26, 2002, 
Belfast, Northern Ireland. 
Michel, A.L., 2002b, ‘Implications of tuberculosis in African wildlife and livestock’, 
Annals of New York Academy of Sciences 969, 251–255. http://dx.doi.
org/10.1111/j.1749-6632.2002.tb04387.x, PMid:12381600
Michel, A.L., Bengis, R.G., Keet, D.F., Hofmeyr, M., De Klerk, L-M., Cross, P.C. et al., 
2006, ‘Wildlife tuberculosis in South African conservation areas: Implications and 
challenges’, Veterinary Microbiology 112, 91–100. http://dx.doi.org/10.1016/j.
vetmic.2005.11.035, PMid:16343819
Michel, A.L., Meyer, S., McCrindle, C.M. & Veary, C.M., 2004, ‘Community 
based veterinary public health systems, current situation, future trends and 
recommendations’, FAO Expert Consultation on Community Based Veterinary 
Public Health Systems, viewed n.d., from http://www.fao.org/ag/againfo/
programmes/en/vph/events/expert_consult_report.pdf
Michel, A.L., Müller, B. & Van Helden, P.D., 2010, ‘Mycobacterium bovis at the animal–
human interface: A problem, or not?’, Veterinary Microbiology 140, 371–381. 
http://dx.doi.org/10.1016/j.vetmic.2009.08.029, PMid:19773134
Mignard, S., Pichat, C. & Carret, G., 2006, ‘Mycobacterium bovis infection, Lyon, 
France’, Emerging Infectious Diseases 12(9), 1431–1433. http://dx.doi.
org/10.3201/eid1209.060209, PMid:17073096
Mikota, S.K., Peddie, L., Peddie, J., Isaza, R., Dunker, F., West, G. et al., 2001, 
‘Epidemiology and diagnosis of Mycobacterium tuberculosis in captive Asian 
elephants (Elephas maximus)’, Journal of Zoology and Wildlife Medicine 32, 1–16. 
PMid:12790389
Muller, B., Hilty, M., Berg, S., Garcia-Pelayo, M.C., Dale, J., Boschiroli, M.L. et al., 2009, 
‘African 1, an epidemiologically important clonal complex of Mycobacterium bovis 
dominant in Mali, Nigeria, Cameroon, and Chad’, Journal of Bacteriology 191, 
1951–1960. http://dx.doi.org/10.1128/JB.01590-08, PMid:19136597
Murphree, R., Warkentin, J.V., Dunn, J.R., Schaffner, W. & Jones, T.F., 2011, ‘Elephant-
to-human transmission of tuberculosis’, Emerging Infectious Diseass 7, 366–371.
Murray, M. & Alland, D.A., 2002, ‘Methodological problems in the molecular 
epidemiology of tuberculosis’, American Journal of Epidemiology 155, 565–571. 
http://dx.doi.org/10.1093/aje/155.6.565, PMid:11882530
Ngowi, B.J., Mfinanga, S.G., Bruun, J.N. & Morkve, O., 2008, ‘Pulmonary tuberculosis 
among people living with HIV/AIDS attending care and treatment in rural northern 
Tanzania’, BMC Public Health 8, 341. http://dx.doi.org/10.1186/1471-2458-8-341, 
PMid:18826574
Osofsky, S.A., Cleaveland, S., Karesh, W.B., Kock, M.D., Nyhua, P.J., Starr, L. et al. 
(Eds.), 2005, Conservation and Development Intervention at the Wildlife/Livestock 
Interface: Implications for Wildlife, Livestock and Human Health, IUCN, Gland, 
Switzerland and Cambridge, UK.
Palmer, M.V., 2007, ‘Tuberculosis: A reemerging disease at the interface of domestic 
animals and wildlife’, Current Topics in Microbiology and Immunology 315, 195–
215. http://dx.doi.org/10.1007/978-3-540-70962-6_9
Rodriguez, J.G., Fissanoti, J.C., Del Portillo, P., Patarroyo, M.E., Romano, M.I. & 
Cataldi, A., 1999, ‘Amplification of a 500-base-pair fragment from cultured 
isolates of Mycobacterium bovis’, Journal of Clinical Microbiology 37, 2330–2332. 
PMid:10364607
Rodriguez, J.G., Mejia, G.A., Del Portillo, P., Patarroyo, M.E. & Murillo, L.A., 1995, 
‘Species-specific identification of Mycobacterium bovis by PCR’, Microbiology 141, 
2131–2138. http://dx.doi.org/10.1099/13500872-141-9-2131, PMid:7496524
Romano, M.I., Alito, A., Bigi, F., Fisanotti, J.C. & Cataldi, A., 1995, ‘Genetic 
characterization of mycobacteria from South American wild seals’, Veterinary 
Microbiology 47, 89–98. http://dx.doi.org/10.1016/0378-1135(95)00103-H
Romano, M.I., Alito, A., Fisanotti, J.C., Bigi, F., Kantor, I., Cicuta, M.E. et al., 1996, 
‘Comparison of different genetic markers for molecular epidemiology of bovine 
tuberculosis’, Veterinary Microbiology 50, 59–71. http://dx.doi.org/10.1016/0378-
1135(95)00197-2
Sechi, L.A., Zanetti, S., Sanguinetti, M., Molicotti, P., Romano, L., Leori, G. et al., 
2001, ‘Molecular basis of rifampin and isoniazid resistance in Mycobacterium 
bovis strains isolated in Sardinia, Italy’, Antimicrobial. Agents and 
Chemotherapy 45, 1645–1648. http://dx.doi.org/10.1128/AAC.45.6.1645-
1648.2001, PMid:11353606
Shirima, G.M., Kazwala, R.R. & Kambarage, D.M., 2003, ‘Prevalence of bovine 
tuberculosis in cattle in different farming systems in the eastern zone of Tanzania’, 
Preventive Veterinary Medicine 57, 167–172. http://dx.doi.org/10.1016/S0167-
5877(02)00214-3
Smith, N.H., Berg, S., Dale, J., Allen, A., Rodriguez, S., Romero, B. et al., 2011, 
‘European 1: A globally important clonal complex of Mycobacterium bovis’, 
Infection, Genetics and Evolution 11, 1340–1351. http://dx.doi.org/10.1016/j.
meegid.2011.04.027, PMid:21571099
Torgerson, P. & Torgerson, D., 2009, ‘Benefits of stemming bovine TB need to be 
demonstrated’, Nature 457, 657–657. http://dx.doi.org/10.1038/457657d, 
PMid:19194427
WHO/DFID, 2006, ‘The control of neglected zoonotic diseases - a route to poverty 
alleviation. Report of a joint WHO/DFID-Animal Health Programme meeting with 
the participation of FAO and OIE’, Geneva 20 and 21 Sept 2005, WHO, Geneva, 
viewed n.d., from http://www.who.int/zoonoses/Report_Sept06.pdf
WHO, 2004, ‘Report of the WHO/FAO/OIE joint consultation on emerging zoonotic 
diseases -in collaboration with the Health Council of the Netherlands’, 03–05 May 
2004, Geneva, Switzerland.
Wirth, T., Hildebrand, F., Allix-Béguec, C., Wölbeling, F., Kubica, T., Kremer, K. et al., 
2008, ‘Origin, spread and demography of the M. tuberculosis complex’, PLoS 
Pathogens 4, e1000160. http://dx.doi.org/10.1371/journal.ppat.1000160, 
PMid:18802459
Wolfe, N.D., Dunavan, C.P. & Diamond, J., 2007, ‘Origins of major human infectious 
diseases’, Nature 447, 279–283. http://dx.doi.org/10.1038/nature05775, 
PMid:17507975
Woodroffe, R., Donnelly, C.A., Cox, D.R., Gilks, P., Jenkins, H.E., Johnston, W.T. et al., 
2009, ‘Bovine tuberculosis in cattle and badgers in localized culling areas’, Journal 
of Wildlife Diseases 45, 128–143. PMid:19204342
Zumarraga, M.J., Martin, C., Samper, S., Alito, A., Latini, O., Bigi, F. et al., 1999, 
‘Usefulness of spoligotyping in molecular epidemiology of Mycobacterium bovis-
related infections in South America’, Journal of Clinical Microbiology 37, 296–303. 
PMid:9889207
